Oncology
Cancer Sequencing Becomes the Operating System of Precision Oncology
ASCO 2026 showed how comprehensive genomic solutions are moving from research support to the practical backbone of cancer detection, profiling, monitoring and treatment matching.
Personalised Cancer Vaccines Show Longer-Term Staying Power
Oral SERDs Face the Hard Test: Where Do They Actually Fit?
Prostate Cancer Value Starts Counting Cognition
China’s PD-1/VEGF Bet Challenges the Lung Cancer Backbone
The ASCO Drug Race Still Runs Through Genomic Testing
High-Risk Prostate Cancer Moves Before the Metastatic Clock Starts
Physical activity continues to strengthen its case as a cross-disease prevention strategy
An ADC Steps Into the First-Line Gap in Triple-Negative Breast Cancer
Alpha Radioligand Therapy Moves Prostate Cancer Into a New Infrastructure Test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.